NCT05563870Completed
Endoscopy and Radiology-guided Ablation for Inoperable Cholangiocarcinoma
A Combined Endoscopy and Radiology-guided Radiofrequency Ablation Therapy Protocol for Inoperable Perihilar Cholangiocarcinoma
Source: ClinicalTrials.gov · Last updated 29 Jul 2026
Brief summary (registry, in English)
This prospective clinical trial aims to assess the feasibility, efficacy, and safety of a personalized radiofrequency ablation protocol coupled with complete biliary drainage for patients presenting with inoperable perihilar cholangiocarcinoma.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 26 (actual)
- First submitted
- 20 Sept 2022
- Start date
- 1 Aug 2022
- Primary completion date
- 20 Jul 2026
- Lead sponsor
- Clinical Hospital Colentina
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT05563870
What you commit to
- Study type: Interventional
- Participants enrolled: 26
- From 1 Aug 2022 to the primary completion date, 20 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- refusal to sogn the ICF
- poor performance status (ECOG \>2)
- surgically altered anatomy (i.e Bilroth II or Roux-en-Y interventions)
- significant comorbidities
- ASA score \>3
- life expectancy \<3 months
Who the study is looking for
- perihilar cholangiocarcinoma
- locally advanced disease (unresectable)
- M1 (limted to 1 site)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Gastroenterology Department, Colentina Hospital Coordinator of this site? Confirm its status | Bucharest | Romania | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.